BioCentury | Jul 25, 2016
Financial News

Sygnis completes private placement

...sold in a concurrent rights offering and those issued as part of the acquisition of Expedeon Ltd....
BioCentury | Jul 25, 2016
Financial News

Sygnis completes rights offering

...sold in a concurrent private placement and those issued as part of the acquisition of Expedeon Ltd....
BioCentury | Dec 5, 2011
Company News

Expedeon, Protein Discovery deal

...Expedeon and Protein Discovery merged, with Expedeon remaining as the surviving entity. The newco will supply...
...products include its Gelfree 8100 Fractionation System, FASP Protein digestion kits and PPS Silent Surfactant. Expedeon's...
...Protein Discovery founder and CEO Chuck Witkowski will join Expedeon's board. Details were not disclosed. Expedeon Ltd....
Items per page:
1 - 3 of 3
BioCentury | Jul 25, 2016
Financial News

Sygnis completes private placement

...sold in a concurrent rights offering and those issued as part of the acquisition of Expedeon Ltd....
BioCentury | Jul 25, 2016
Financial News

Sygnis completes rights offering

...sold in a concurrent private placement and those issued as part of the acquisition of Expedeon Ltd....
BioCentury | Dec 5, 2011
Company News

Expedeon, Protein Discovery deal

...Expedeon and Protein Discovery merged, with Expedeon remaining as the surviving entity. The newco will supply...
...products include its Gelfree 8100 Fractionation System, FASP Protein digestion kits and PPS Silent Surfactant. Expedeon's...
...Protein Discovery founder and CEO Chuck Witkowski will join Expedeon's board. Details were not disclosed. Expedeon Ltd....
Items per page:
1 - 3 of 3